Future studies on GCase deficiency should investigate whether lysosomal parameters are affected in more physiologically representative models of disease, such as neuronal models that incorporate key proxies of synucleinopathies (e.g., α-synuclein oligomers, SNCA mutations, or microglial inflammation). This evidence concerns the gene SNCA and synucleinopathy.